Bartholomew, T. S., Plesons, M., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez, E., Forrest, D. W., Chueng, T. A., Ciraldo, K., Brooks, J., Smith, J. D., Barocas, J. A., & Tookes, H. E. (2024). Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addiction Science & Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00447-9

Goodman-Meza, D., Shoptaw, S., Hanscom, B., Smith, L. R., Andrew, P., Kuo, I., Lake, J. E., Metzger, D., Morrison, E. A. B., Cummings, M., Fogel, J. M., Richardson, P., Harris, J., Heitner, J., Stansfield, S., & El-Bassel, N. (2024). Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study). Trials, 25(1). https://doi.org/10.1186/s13063-023-07899-5

Uusküla, A., Raag, M., Barnes, D. M., Tross, S., Ave, T., & Des Jarlais, D. C. (2023). Adapted “Break the Cycle for Avant Garde” intervention to reduce injection assisting and promoting behaviours in people who inject drugs in Tallinn, Estonia: A pre- post trial. PLOS ONE, 18(5), e0266815. https://doi.org/10.1371/journal.pone.0266815

Massey, E. S. G., Bazzi, A. R., Sian, C. R., Gebel, C. M., Bernstein, J. A., & Assoumou, S. A. (2022). “I’ve been 95% safe”: perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study. AIDS Care, 35(4), 461–465. https://doi.org/10.1080/09540121.2022.2031853

Martel-Laferrière, V., Feaster, D. J., Metsch, L. R., Schackman, B. R., Loignon, C., Nosyk, B., Tookes, H., Behrends, C. N., Arruda, N., Adigun, O., Goyer, M.-E., Kolber, M. A., Mary, J.-F., Rodriguez, A. E., Yanez, I. G., Pan, Y., Khemiri, R., Gooden, L., Sako, A., & Bruneau, J. (2022). M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials, 23(1). https://doi.org/10.1186/s13063-022-06085-3

El-Bassel, N., McCrimmon, T., Wu, E., Chang, M., Terlikbayeva, A., Hunt, T., Darisheva, M., Primbetova, S., Davis, A., Metsch, L. R., Feaster, D. J., Baiserkin, B., Abishev, A., Denebayeva, A., Sagimbayev, B., Kurmetova, K., Mashirov, K., & Gilbert, L. (2022). Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan. JAMA Network Open, 5(12), e2244734. https://doi.org/10.1001/jamanetworkopen.2022.44734

Bazzi, A. R., Valasek, C. J., Streuli, S. A., Vera, C. F., Harvey-Vera, A., Philbin, M. M., Biello, K. B., Roth, A. M., Strathdee, S. A., & Pines, H. A. (2022). Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California. AIDS Patient Care and STDs, 36(7), 254–262. https://doi.org/10.1089/apc.2022.0068

McCrimmon, T., Sundelson, A., Darisheva, M., Gilbert, L., Hunt, T., Terlikbayeva, A., Primbetova, S., & El-Bassel, N. (2022). HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives. Global Health: Science and Practice, 10(2), e2100619. https://doi.org/10.9745/ghsp-d-21-00619